First monoclonal antibody treatment approved for prevention of COVID-19
Pharmaceutical journal/The pharmaceutical journal · 2022
A new monoclonal antibody cocktail has been authorised by the Medicines and Healthcare products Regulatory Agency (MHRA) for the prevention of COVID-19. Evusheld (AstraZeneca) is a combination of two monoclonal antibodies — tixagevimab and cilgavimab — and works by binding to the spike protein of the SARS-CoV-2 virus, preventing it from attaching and entering human […]